These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19411385)

  • 1. Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome.
    Kemp DE; Ismail-Beigi F; Calabrese JR
    Am J Psychiatry; 2009 May; 166(5):619. PubMed ID: 19411385
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity.
    Kemp DE; Ismail-Beigi F; Ganocy SJ; Conroy C; Gao K; Obral S; Fein E; Findling RL; Calabrese JR
    J Affect Disord; 2012 Feb; 136(3):1164-73. PubMed ID: 21782251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pioglitazone effects on blood pressure in patients with metabolic syndrome].
    Takahashi A; Kushiro T
    Nihon Rinsho; 2008 Aug; 66(8):1591-5. PubMed ID: 18700562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.
    Kashani L; Omidvar T; Farazmand B; Modabbernia A; Ramzanzadeh F; Tehraninejad ES; Ashrafi M; Tabrizi M; Akhondzadeh S
    Psychoneuroendocrinology; 2013 Jun; 38(6):767-76. PubMed ID: 22999261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled trial of pioglitazone for bipolar depression.
    Aftab A; Kemp DE; Ganocy SJ; Schinagle M; Conroy C; Brownrigg B; D'Arcangelo N; Goto T; Woods N; Serrano MB; Han H; Calabrese JR; Gao K
    J Affect Disord; 2019 Feb; 245():957-964. PubMed ID: 30699881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
    Smith RC; Jin H; Li C; Bark N; Shekhar A; Dwivedi S; Mortiere C; Lohr J; Hu Q; Davis JM
    Schizophr Res; 2013 Jan; 143(1):18-24. PubMed ID: 23200554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response.
    Lin KW; Wroolie TE; Robakis T; Rasgon NL
    Psychiatry Res; 2015 Dec; 230(3):846-52. PubMed ID: 26602230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IRIS III study: pioglitazone improves metabolic control and blood pressure in patients with type 2 diabetes without increasing body weight.
    Schöndorf T; Forst T; Hohberg C; Pahler S; Link C; Roth W; Pfützner A; Lübben G; Link C; Pfützner A
    Diabetes Obes Metab; 2007 Jan; 9(1):132-3. PubMed ID: 17199730
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of metabolic profile and adiponectin level with pioglitazone versus voglibose in patients with type-2 diabetes mellitus associated with metabolic syndrome.
    Fujitaka K; Otani H; Jo F; Jo H; Nomura E; Iwasaki M; Nishikawa M; Iwasaka T
    Endocr J; 2011; 58(6):425-32. PubMed ID: 21498915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan and pioglitazone ameliorate nephropathy in experimental metabolic syndrome rats.
    Kong X; Zhang DY; Wu HB; Li FX
    Biol Pharm Bull; 2011; 34(5):693-9. PubMed ID: 21532159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of antipsychotic-associated hyperglycemia with pioglitazone: a case series.
    Edlinger M; Ebenbichler C; Rettenbacher M; Fleischhacker WW
    J Clin Psychopharmacol; 2007 Aug; 27(4):403-4. PubMed ID: 17632231
    [No Abstract]   [Full Text] [Related]  

  • 12. Pioglitazone treatment of insulin resistance in a patient with Werner's syndrome.
    Hattori S; Kasai M; Namatame T; Hattori Y; Kasai K
    Diabetes Care; 2004 Dec; 27(12):3021-2. PubMed ID: 15562234
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort).
    Singh S; Bhansali A
    BMC Dermatol; 2016 Aug; 16(1):12. PubMed ID: 27531132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.
    McIntyre RS; Park KY; Law CW; Sultan F; Adams A; Lourenco MT; Lo AK; Soczynska JK; Woldeyohannes H; Alsuwaidan M; Yoon J; Kennedy SH
    CNS Drugs; 2010 Sep; 24(9):741-53. PubMed ID: 20806987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome.
    Warshauer JT; Lopez X; Gordillo R; Hicks J; Holland WL; Anuwe E; Blankfard MB; Scherer PE; Lingvay I
    Diabetes Metab Res Rev; 2015 Oct; 31(7):734-44. PubMed ID: 25959529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.
    Vu A; Kosmiski LA; Beitelshees AL; Prigeon R; Sidhom MS; Bredbeck B; Predhomme J; Deininger KM; Aquilante CL
    Pharmacotherapy; 2016 Mar; 36(3):252-62. PubMed ID: 26822630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of pioglitazone and rosiglitazone in type 2 diabetes, prediabetes, and the metabolic syndrome: a meta-analysis.
    Norris SL; Carson S; Roberts C
    Curr Diabetes Rev; 2007 May; 3(2):127-40. PubMed ID: 18220664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin Resistance Intervention After Stroke Trial of Pioglitazone: Is This Perhaps the End of the Beginning?
    Ntaios G; Kent TA
    Stroke; 2016 Jul; 47(7):1962-4. PubMed ID: 27222525
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of pioglitazone on metabolic syndrome risk factors: results of double-blind, multicenter, randomized clinical trials.
    Rajagopalan R; Iyer S; Khan M
    Curr Med Res Opin; 2005 Jan; 21(1):163-72. PubMed ID: 15881488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic improvement and abdominal fat redistribution in Werner syndrome by pioglitazone.
    Yokote K; Honjo S; Kobayashi K; Fujimoto M; Kawamura H; Mori S; Saito Y
    J Am Geriatr Soc; 2004 Sep; 52(9):1582-3. PubMed ID: 15341572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.